Palisade Bio (PALI) Total Debt (QoQ) (2013 - 2025)
Palisade Bio (PALI) Total Debt (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 256.06% |
| Jun 30, 2025 | -4.35% |
| Jun 30, 2024 | 4.20% |
| Mar 31, 2024 | 0.00% |
| Mar 31, 2017 | -32.09% |
| Dec 31, 2016 | -13.07% |
| Sep 30, 2016 | -11.13% |
| Jun 30, 2016 | 37.92% |
| Mar 31, 2016 | -11.55% |
| Dec 31, 2015 | -12.72% |
| Sep 30, 2015 | 1.12% |
| Jun 30, 2015 | 1.11% |
| Mar 31, 2015 | 1.11% |
| Dec 31, 2014 | 54.97% |
| Sep 30, 2014 | -10.97% |
| Jun 30, 2014 | -9.57% |
| Mar 31, 2014 | -8.51% |
| Dec 31, 2013 | 0.65% |
| Sep 30, 2013 | 0.63% |
| Jun 30, 2013 | 0.62% |